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8-methoxypsoralen	 is	 a	 photoac3vated	DNA-intercala3ng	 agent,	which	
a<er	 absorbing	 two	 high-energy	 UVA	 photons,	 covalently	 binds	
pyrimidine	bases	on	both	DNA	strands,	to	form	an	interstrand	crosslink	
(ICL).	 These	 lesions	 completely	 block	 replica3on	 and	 transcrip3on,	 and	
are	widely	 used	 in	 chemotherapies;	 yet	 the	mechanism	by	which	 they	
are	processed	remains	poorly	understood.	In	1985,	Ahmed	and	Holland	
reported	 an	Escherichia	 coli	mutant	 demonstra3ng	hyper-resistance	 to	
ICL-inducing	agents.	The	muta3on	was	mapped	to	57.2	minutes	on	the	
chromosome,	 and	 poten3ally	 encoded	 a	 55-kDa	 protein	 that	 was	
induced	 as	 part	 of	 the	 SOS	 response.	 Although	 these	 genes	 remain	
uniden3fied,	hscA	and	hscB	map	to	this	loca3on,	have	a	similar	size,	and	
are	 SOS-inducible.	 To	determine	 if	 these	 genes	or	 others	might	 confer	
ICL	 resistance	 in	 E.	 coli,	 we	 characterized	 how	 cells	 survived	 PUVA	
treatment	in	the	absence	of	HscAB,	and	when	these	gene	products	were	
overexpressed.	In	a	second	approach	to	screen	for	ICL	resistance	genes,	
we	 developed	 a	 selec3on	 system	 to	 isolate	 hyper-resistant	 strains	
through	 the	 sequen3al	 growth	 and	 exposure	 of	 wild-type	 cultures	 to	
PUVA.	 We	 found	 no	 effect	 on	 cell	 survival	 in	 the	 hscAB	 mutant	
compared	 to	 its	 wild-type	 parent,	 sugges3ng	 that	 HscAB	 may	 not	 be	
contribu3ng	to	ICL	resistance	as	previously	hypothesized.	However,	due	
to	the	significant	cytotoxicity	of	plasmids	containing	hscAB,	even	in	the	
absence	 of	 PUVA	 treatment,	 we	 were	 unable	 to	 determine	 whether	
over-expression	 of	 these	 gene	 products	 might	 provide	 a	 protec3ve	
effect	to	cells.	Using	itera3vely	PUVA	cells,	we	isolated	strains	that	were	
>104-fold	 more	 resistant	 to	 this	 ICL-inducing	 agent	 compared	 to	 the	
parent	 strain.	 This	 result	 suggests	 that	 E.	 coli	 possess	 mechanisms	 to	







































































































































Interstrand	 crosslinking	 agents	 are	 potent	 chemotherapeu3cs,	 yet	
cancer	 cells	 o<en	develop	 resistance	 to	 these	 drugs	 through	unknown	
mechanisms.		
	
The	 model	 organism	 E.	 coli	 encodes	 genes	 for	 most	 of	 the	 cellular	
processes	thought	to	be	 involved	 in	resistance	to	 interstrand	crosslinks	
in	 human	 cells,	 including	 nucleo3de	 and	 base	 excision	 repair	 and	
translesion	DNA	synthesis.		
	
Therefore,	we	sought	to	 iden3fy	genes	contribu3ng	to	ICL-resistance	in	
E.	coli	using	targeted	mutagenesis	and	a	general	selec3on	scheme.	
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